This study provides new information about the role of ACE1 within the MnPO in the hypertension associated with CIH and the potential use of ACE blockers that cross the blood‐brain‐barrier in treating hypertension of mild to moderate OSA patients. This evidence concerns the gene ACE and hypertensive disorder.